Andrew H. Briggs

Apr 24, 2024 | thelancet.com | S List |Oliver Carlile |Keppel Street |Andrew H. Briggs

Research in contextWe searched for research published between 1st January 2020 and 1st November 2023, published in English, for the Title/Abstract terms (Post COVID-19 syndrome, PCS, long COVID, post-acute-covid-19) AND (quality-adjusted life-years, QALYs) with only 3 results. 1 described a theoretical framework, 1 estimated cost-effectiveness of COVID-19 self-testing, and 1 estimated the morbidity burden attributable to long COVID symptoms compared to death.

Feb 13, 2023 | nature.com | Aris Angelis |Andrew H. Briggs

In the UK, England’s National Health Service (NHS England) recently launched the Innovative Medicines Fund (IMF) to fast-track promising new drugs, operating on similar terms to — and with the same £340 million budget as — the Cancer Drugs Fund (CDF)1. Both managed-access funds should be exceptional patient-access routes that are used in the case of immature evidence on a drug’s value from randomized interventional studies.